Biol Reprod Keystone Symposia Conference on Frontiers in Reproductive Biology & Regulation of Fertility.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Eyster, K. M.
Right arrow Articles by Sheth, M. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Eyster, K. M.
Right arrow Articles by Sheth, M. V.
Agricola
Right arrow Articles by Eyster, K. M.
Right arrow Articles by Sheth, M. V.

Biology of Reproduction, Vol 58, 338-345, Copyright © 1998 by Society for the Study of Reproduction

ARTICLES

Protein phosphatase activity in the rat ovary throughout pregnancy and pseudopregnancy

KM Eyster, TL Berger, MC Rodrigo and MV Sheth
Department of Physiology and Pharmacology, University of South Dakota School of Medicine, Vermillion 57069-2390, USA. keyster@charlie.usd.edu

Specific protein phosphatase activity against protein kinase C- phosphorylated substrate was measured in the rat ovary during pseudopregnancy and pregnancy. Tissues were processed in the presence of sodium fluoride and inorganic phosphate to inhibit the phosphatase and thereby prevent autodephosphorylation of the type 2A protein phosphatase (PP2A) during homogenization. Manganese was added at the time of enzyme assay to reactivate the phosphatase. The specific activity of the protein phosphatase did not vary significantly across pseudopregnancy (p > 0.05). In contrast, the specific activity of protein phosphatase decreased significantly between Day 7 and Day 10 of pregnancy (28.8 +/- 5 pmol/min x microg protein and 20.7 +/- 2 pmol/min x microg protein, respectively; p < 0.05) and remained at the decreased value for the remainder of pregnancy. To determine whether hormones of pregnancy could regulate PP2A activity in the ovaries, pseudopregnant rats were treated with prolactin (3 IU twice a day), bromocriptine (100 microg twice a day), or estradiol benzoate (50 microg). Bromocriptine and estradiol treatments caused a decrease in PP2A-specific activity, but prolactin had no effect. Bromocriptine treatment caused a decrease in the protein content of the PP2A catalytic subunit, but prolactin and estradiol treatments had no effect. The data suggest that the specific activity and protein content of PP2A in the rat ovary are hormonally regulated.


This article has been cited by other articles:


Home page
 J EndocrinolHome page
M. V Sheth, C. J Mark, and K. M Eyster
Expression of type 1 and 2A protein phosphatase subunits in the rat corpus luteum across pregnancy
J. Endocrinol., November 1, 2007; 195(2): 293 - 299.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. C. Rodrigo, D. S. Martin, and K. M. Eyster
Estrogen decreases biglycan mRNA expression in resistance blood vessels
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2003; 285(4): R754 - R761.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
S. R. Inamdar, K. M. Eyster, and E. H. Schlenker
Genome and Hormones: Gender Differences in Physiology: Selected Contribution: Estrogen receptor-{alpha} antisense decreases brain estrogen receptor levels and affects ventilation in male and female rats
J Appl Physiol, October 1, 2001; 91(4): 1886 - 1892.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by the Society for the Study of Reproduction.